OMNIS is a computational drug safety and pharmaceutical research platform that interprets the human genome as an executable program. It enables researchers to predict drug side effects, simulate gene knockouts, design CRISPR guides and antisense oligonucleotides, and identify synthetic lethal gene pairs — all grounded in the genome's functional dispatch architecture.
The platform includes OMNIS AI (JARVIS), an Anthropic Claude-powered natural language bio-programmer that lets researchers query the genomic database and run complex analyses using plain English. Key tools include the Side Effect Predictor (SPE), CRISPR Guide Designer, ASO Exon-Skip Designer, Synthetic Lethality Finder, Off-Target Effect Predictor, Chromosome Architecture Map, and CDSA Report Generator.
OMNIS is used by pharmaceutical researchers, academic drug discovery labs, and bioinformaticians for pre-IND preparation, lead optimization, and target validation. A 7-day free trial with full platform access is available. Professional plans start at $995/month; academic plans start at $249/month for verified institutional researchers.
Built by OMNIS Architecture Co. — redefining how we read the genome.